Volume 15, Number 1—January 2009
Dispatch
Rotavirus Genotype Distribution after Vaccine Introduction, Rio de Janeiro, Brazil
Table
Vaccination status and year | No. samples | No. (%) rotavirus positive | No. (%) G1P[8] | No. (%) G2P[4] | No. (%) G3P[8] | No. (%) G9P[8] | No. (%) other genotypes, mixed or not typeable |
---|---|---|---|---|---|---|---|
Ineligible for full vaccination† | |||||||
2005 | 193 | 73 (38) | 10 (14) | 1 (1.4) | 22 (30) | 33 (45) | 7 (9.5) |
2006 | 148 | 34 (23) | 1 (2.9) | 14 (41) | 6 (8) | 5 (5) | 8 (23) |
2007 |
49 |
12 (24) |
1 (8) |
11 (92) |
– |
– |
– |
Vaccinated‡ | |||||||
2006 | 6 | Negative§ | |||||
2007 |
33 |
4 (12) |
– |
4 (100) |
– |
– |
– |
Not vaccinated | |||||||
2006 | 8 | Negative§ | |||||
2007 |
27 |
10 (37) |
– |
10 (100) |
– |
– |
– |
Total | 464 | 133 (29) | 12 (9) | 40 (30) | 28 (21) | 38 (29) | 15 (11) |
*–, absence of genotypes.
†Born before January 1, 2006, or <4 months of age.
‡Children were considered vaccinated if they had received 2 doses of vaccine.
§All stool samples were negative for rotavirus.
Page created: November 19, 2010
Page updated: November 19, 2010
Page reviewed: November 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.